tiprankstipranks
Trending News
More News >
Pharvaris’s Strategic Advancements and Clinical Progress Justify Buy Rating
PremiumRatingsPharvaris’s Strategic Advancements and Clinical Progress Justify Buy Rating
26d ago
Pharvaris presents data supporting ongoing clinical development of deucrictibant
Premium
The Fly
Pharvaris presents data supporting ongoing clinical development of deucrictibant
28d ago
Pharvaris: Strong Buy Rating Backed by Clinical Progress and Financial Stability
Premium
Ratings
Pharvaris: Strong Buy Rating Backed by Clinical Progress and Financial Stability
2M ago
Pharvaris reports Q1 EPS EUR (0.85) vs. EUR (0.52) last year
PremiumThe FlyPharvaris reports Q1 EPS EUR (0.85) vs. EUR (0.52) last year
2M ago
Pharvaris Reports Q1 2025 Financials and Advances HAE Treatment Trials
Premium
Company Announcements
Pharvaris Reports Q1 2025 Financials and Advances HAE Treatment Trials
2M ago
Pharvaris initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
Pharvaris initiated with an Overweight at Cantor Fitzgerald
2M ago
Pharvaris Reports 2024 Financial Results and Business Progress
PremiumCompany AnnouncementsPharvaris Reports 2024 Financial Results and Business Progress
3M ago
Pharvaris Positioned for Growth with Successful Trial and Strong Financials, Analyst Projects Significant Market Expansion
Premium
Ratings
Pharvaris Positioned for Growth with Successful Trial and Strong Financials, Analyst Projects Significant Market Expansion
3M ago
Trump threatens even higher tariffs on China after retaliation: Morning Buzz
Premium
The Fly
Trump threatens even higher tariffs on China after retaliation: Morning Buzz
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100